|
Market Closed -
BME
18:35:16 09/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 58.05 EUR | -0.17% |
|
+1.13% | -8.58% |
| 10-05 | Spanish stocks - Factors to watch on Oct 5 | RE |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 |
Main competitors
| P/E (N) | Price to Book (N) | PEG (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 19.61x | 3.87x | 2.57x | 3.82x | 14.98x | 18.01x | 1.68% | 3.32B | |
| 33.55x | 22.23x | 0.63x | 12.18x | 25.21x | 26.74x | 0.58% | 1,051B | |
| 29.08x | 7.13x | -1.57x | 6.43x | 18.37x | 20.28x | 2.04% | 630B | |
| 35.19x | -95.68x | 0.15x | 8.13x | 16.76x | 17.55x | 2.51% | 489B | |
| 105.8x | 7.43x | -1.3x | 5.93x | 25.27x | 33.89x | 2.34% | 359B | |
| 19.31x | 7.2x | 1.24x | 4.72x | 11.72x | 13.01x | 2.8% | 344B | |
| 20.06x | 5.77x | -22.65x | 5.27x | 12.98x | 13.93x | 3.02% | 272B | |
| 20.57x | 4.55x | 1.14x | 4.22x | 12.06x | 12.66x | 2.1% | 246B | |
| 26.34x | 20.02x | 2.47x | 6.83x | 12.21x | 15.69x | 2.43% | 224B | |
| -45.84x | 13.19x | 0.31x | 6.75x | 26.31x | 63.49x | 2.18% | 187B | |
| 11.36x | 4.81x | -4.74x | 4.15x | 8.6x | 10.07x | 4.47% | 169B | |
| 17.86x | 1.86x | 1.09x | 3.36x | 8.5x | 9.83x | 6.08% | 161B | |
| 52.42x | 8.27x | -1.44x | 9.33x | 58.17x | 30.27x | -.--% | 129B | |
| 10.84x | 5.09x | 0.19x | 3x | 8.03x | 8.55x | 4.29% | 121B | |
| 23.73x | -45.68x | 7.74x | 0.26x | 15.19x | 16.24x | 0.39% | 109B | |
| 11.41x | 1.16x | -5.55x | 2.05x | 6.57x | 7.37x | 5.95% | 95.94B | |
| 13.59x | 4.38x | -1.56x | 2.69x | 7.85x | 8.84x | 3.97% | 92.79B | |
| -26.83x | 15.57x | -1.73x | 40.89x | -26.56x | -24.66x | -.--% | 89.83B | |
| 16.67x | 2.23x | 2.09x | 3.89x | 8.92x | 10.32x | 0.52% | 74.55B | |
| 23.34x | 1.97x | -14.9x | 3.15x | 11.01x | 18.31x | 1.7% | 67.11B | |
| Average | 20.90x | -0.23x | -1.79x | 6.85x | 14.11x | 16.52x | 2.45% | 245.85B | |
| Weighted average by Cap. | 28.80x | -0.83x | -1.46x | 7.59x | 17.69x | 20.30x | 2.16% |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
